Kelly T, Yang W, Chen C-S, Reynolds K, He J
Tirzepatide produced greater A1c reductions than semaglutide in the SURPASS-2 head-to-head trial, making it the stronger option for glycemic control
We want to make sure that youre on the right dose for you, or we may suggest a different medication or add on a complementary medication for weight management, says Dr
Ozempic and Wegovy have narrow maximal dosage differences (2.0 mg weekly and 2.4 mg weekly, respectively), so they are both effective at controlling blood glucose and promoting weight loss
For men using compounded tirzepatide , reconstitution becomes a relevant skill
There are many reasons that people stop these medications, including side effects, lack of medication availability, achievement of targeted weight loss, and insurance difficulties or inability to afford out-of-pocket costs